Retinopathy and microalbuminuria in type II diabetic patients

BMC Ophthalmology
Masoud R ManaviatMohammad R Shoja

Abstract

The aim of this study was to identify risk factors for the development of retinopathy and microalbuminuria and their correlation in type II diabetic patients. In this cross-sectional study 590 patients suffering from diabetes type II were examined. Fundoscopy was performed by practising ophthalmologist. The ratio of urinary albumin to creatinine was assessed by clinitek 100 (Bayer corporation-USA). HbA1C, height and weight also were measured. The overall prevalence of retinopathy was 39.3% (232 patients), 5.4% of which showed to be proliferative diabetic retinopathy (PDR). The diabetic retinopathy had significant inverse correlation with body mass index (BMI) (P = 0.02). HbA1C was higher in patients with PDR (mean = 10.5%) than in patients with no signs of retinopathy (mean = 9.5%) and this difference was statistically significant (P = 0.001). The prevalence of microalbuminuria was 25.9% while 14.5% of the patients revealed to have macroalbuminuria. As expected, diabetic retinopathy and renal involvement were highly positively correlated. (P = 0.001). Microalbuminuria is associated with diabetic retinopathy in type II diabetic patients and is a reliable marker of retinopathy.

References

Oct 1, 1993·Diabetes Care·R KleinS E Moss
Jun 1, 1993·Scandinavian Journal of Primary Health Care·R EggertsenG Blohmé
Apr 1, 1996·Journal of the Royal Society of Medicine·S A Evans
Aug 26, 1998·Diabetes Research and Clinical Practice·C H KimK U Lee
Aug 26, 1999·Diabetes Research and Clinical Practice·E SobngwiK B Ngu

❮ Previous
Next ❯

Citations

Nov 14, 2007·Cell and Tissue Research·Raimund HirschbergGrace M Mitu
Jan 1, 2008·Journal of Molecular Histology·Taoufik KhalfaouiAmel Ouertani-Meddeb
Jun 10, 2010·Journal of Molecular Histology·Taoufik KhalfaouiAmel Ouertani-Meddeb
Jun 8, 2011·International Ophthalmology·Masoud Reza ManaviatMariaEsther Bandala-Sanchez
Jan 12, 2010·American Journal of Epidemiology·Simerjot K JassalElizabeth Barrett-Connor
Aug 17, 2005·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Homoud Al-ZuabiMai H Al-Suwayan
Sep 4, 2008·Investigative Ophthalmology & Visual Science·Nedal H ArarUNKNOWN Family Investigation of Nephropathy and Diabetes Research Group
Jul 4, 2012·Diabetology & Metabolic Syndrome·Ho RaYong Kyun Kim
Oct 23, 2013·PloS One·Miguel Á Salinero-FortUNKNOWN MADIABETES Group
Dec 18, 2013·Middle East African Journal of Ophthalmology·Jacob KoshyThomas Mathew
Mar 5, 2014·BMC Endocrine Disorders·Prasad KatulandaDavid R Matthews
May 20, 2017·International Ophthalmology·Shreyas TemkarPradeep Venkatesh
Apr 25, 2016·Annals of Global Health·Sina NoshadAlireza Esteghamati
Sep 18, 2018·Ophthalmic Surgery, Lasers & Imaging Retina·Lucas Brandolt FariasLuis Henrique Canani
Feb 18, 2016·PloS One·Antonio Rodríguez-PoncelasGabriel Coll-de Tuero
Jan 1, 2015·Journal of Diabetes and Metabolic Disorders·Mojgan SanjariAmirfarhad Ghaseminejad Tafreshi
Mar 19, 2014·Journal of Diabetes·Charumathi SabanayagamTien Yin Wong
Mar 20, 2019·Reviews in Endocrine & Metabolic Disorders·Masoud MohammadiNader Salari
Nov 22, 2019·Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India·Prateek RoyD Himanshu
Jun 18, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Roqayeh AliyariAhmad-Reza Baghestani
Dec 17, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·S A Al-AnsariC P Hanson
Aug 21, 2020·Translational Vision Science & Technology·Yoo-Ri ChungKihwang Lee
Apr 4, 2021·Journal of Clinical Medicine·Warren W PanJennifer L Harder
Nov 28, 2019·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Veysel CankurtaranFaruk Turgut
Oct 29, 2021·Indian Journal of Ophthalmology·Deep C SainiRaunaq Poonia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.